Myasthenia gravis as a rare complication of graft-versus-host disease following allogenic bone marrow transplantation.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 188
- By:
- Publication type:
- Article
Works matching IS 2717011X AND DT 2021 AND VI 20 AND IP 3
Results: 10
1
2
Beta-thalassemia intermedia with ischemic transients misdiagnosed as multiple sclerosis: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
3
Environmental risk factors of multiple sclerosis in the Middle East and North Africa region: A systematic review.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 166
- By:
- Publication type:
- Article
4
Myasthenia gravis and coronavirus disease 2019: A report from Iran.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 162
- By:
- Publication type:
- Article
5
Cost-effectiveness of ocrelizumab for treatment of Iranian patients with relapsing multiple sclerosis.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 154
- By:
- Publication type:
- Article
6
Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 146
- By:
- Publication type:
- Article
7
Prevalence of coronavirus disease 2019 in patients with neuromyelitis optica in Isfahan, Iran, and a review on recent reports and literature.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 139
- By:
- Publication type:
- Article
8
Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 131
- By:
- Publication type:
- Article
9
Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 125
- By:
- Publication type:
- Article
10
Electrophysiological studies in patients with seropositive/seronegative myasthenia gravis.
- Published in:
- Current Journal of Neurology, 2021, v. 20, n. 3, p. 120
- By:
- Publication type:
- Article